FTXH Among Health Care ETFs
End-of-day Nov 16, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −1.3% | +5.2% | +7.8% | +33.6% | +40.2% | +89.8% | +71.9% | +142.6% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$84 of every $1,000 in FTXH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.36% | $835.89 | 69K | $99.0M |
| 2 | ABBVAbbVie | Healthcare | 7.71% | $770.72 | 309K | $91.2M |
| 3 | JNJJohnson & Johnson | Healthcare | 7.20% | $720.02 | 298K | $85.2M |
| 4 | PFEPfizer | Healthcare | 6.80% | $679.98 | 2.8M | $80.5M |
| 5 | MRKMerck | Healthcare | 6.70% | $669.86 | 537K | $79.3M |
| 6 | VTRSViatris | Healthcare | 4.22% | $422.36 | 2.4M | $50.0M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 4.01% | $400.52 | 50K | $47.4M |
| 8 | BIIBBiogen | Healthcare | 3.92% | $391.74 | 183K | $46.4M |
| 9 | GILDGilead Sciences | Healthcare | 3.85% | $384.67 | 271K | $45.5M |
| 10 | ZTSZoetis | Healthcare | 3.64% | $364.12 | 514K | $43.1M |
| 11 | AMGNAmgen | Healthcare | 3.63% | $362.78 | 92K | $42.9M |
| 12 | UTHRUnited Therapeutics | Healthcare | 3.44% | $344.40 | 69K | $40.8M |
| 13 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.31% | $331.28 | 73K | $39.2M |
| 14 | INCYIncyte | Healthcare | 3.25% | $325.15 | 318K | $38.5M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.18% | $317.98 | 593K | $37.6M |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.36% |
| 2 | ABBV | AbbVie | 7.71% |
| 3 | JNJ | Johnson & Johnson | 7.20% |
| 4 | PFE | Pfizer | 6.80% |
| 5 | MRK | Merck & | 6.70% |
| 6 | VTRS | Viatris | 4.22% |
| 7 | REGN | Regeneron Pharmaceuticals | 4.01% |
| 8 | BIIB | Biogen | 3.92% |
| 9 | GILD | Gilead Sciences | 3.85% |
| 10 | ZTS | Zoetis | 3.64% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |